Safety and Efficacy of RM-001 (Autologous HBG1/2 Promoter-modified CD34+ Hematopoietic Stem and Progenitor Cells) in Patients with Transfusion-Dependent β-ThalassemiaRongrong Liu,Li Wang, Hui Xu,Xiaolin Yin, Junbin Liang,Wenqiang Xie,Gaohui Yang,Yaoyun Li,Yali Zhou, Lei Shi,Bin Xiao,Lingling Shi,Zeyan Shi,Xuemei Zhou,Xiangmin Xu,Jianpei Fang,Yongrong Lai,Junjiu Huang, Xinhua ZhangBlood(2023)引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要